Journal of Materials Chemistry B · 2020 · 14 citations · 24 references
PharmacyOncologyPharmacologyChemotherapyDrug DeliveryNanoparticle Drug DeliveryCancer NanomedicineNanocarriers For TherapeuticsNanomedicineNanoparticle DesignTheranostic NanoparticlesUltrasound In OncologyActive Tumor TargetingBreast Cancer ChemotherapyCancer NanotherapyNanoparticle-based ChemotherapyTheranostic UltrasoundTumor Targeting LigandsTumor-targeted Drug DeliveryUltrasound Contrast Agents
Y<sub>1</sub> receptor ligand-modified nanobubbles could target breast cancer cells and improve therapeutic efficacy with reduced side effects under ultrasound irradiation during chemotherapy.
24
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2018 · 17K citations · Full text
Targeted drug delivery to tumors: Myths, reality and possibility
You Han Bae, Kinam Park · Journal of Controlled Release · 2011 · 1.9K citations · Full text
Pharmacy, Oncology, Pharmacology +12
Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse
Marco Demaria, Monique N. O’Leary, Jianhui Chang et al. · Cancer Discovery · 2016 · 1.3K citations · Full text
Tumour heterogeneity in the clinic
Philippe L. Bédard, Aaron R. Hansen, Mark J. Ratain et al. · Nature · 2013 · 1.2K citations · Full text
Medicine, Cancer Biology, Oncology +10
Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
Kristen M. Turner, Viraj Deshpande, Doruk Beyter et al. · Nature · 2017 · 898 citations